Study on the effectiveness and safety of bronchodilators and inhaled steroids in the treatment of bronchiectasis
支气管舒张剂及吸入激素对支气管扩张治疗的有效性及安全性研究

摘要

目的 观察对支气管扩张患者开展支气管舒张剂及吸入激素治疗的效果以及安全性。方法 前瞻性纳入2024年4月至2025年8月支气管扩张患者76例，数字表随机抽样均分2组，对照组（38例）进行常规治疗，观察组（38例）进行支气管舒张剂及吸入激素治疗。对患者肺功能、症状改善用时以及不良反应进行统计。结果 肺功能水平，观察组治疗后高于对照组，（P<0.05）。症状改善用时，观察组短于对照组，（P<0.05）。不良反应发生率，观察组与对照组无明显差异，（P>0.05）。结论 对支气管扩张患者进行支气管舒张剂及吸入激素治疗，有助于改善患者各方面症状，促进患者肺功能进行恢复，且不会增加患者治疗期间不良反应发生率，可以保障治疗过程中的安全性。

Abstract

Objective To observe the efficacy and safety of bronchodilators and inhaled steroids in the treatment of patients with bronchiectasis.
Methods A prospective study was conducted on 76 patients with bronchiectasis from April 2024 to August 2025. The patients were randomly divided into two groups using a digital table. The control group (38 cases) received conventional treatment, while the observation group (38 cases) received bronchodilators and inhaled steroids. Statistical analysis of patients' lung function, symptom improvement time, and adverse reactions.
Results The lung function level in the observation group was higher than that in the control group after treatment, (P<0.05). The improvement time of symptoms in the observation group was shorter than that in the control group, (P<0.05). The incidence of adverse reactions showed no significant difference between the observation group and the control group, (P>0.05).
Conclusion   Treatment with bronchodilators and inhaled steroids for patients with bronchiectasis can improve various symptoms, promote the recovery of lung function, and does not increase the incidence of adverse reactions during treatment, ensuring the safety of the treatment process.